From Bloomberg News. There is contact info at base
Post# of 36728
Somebody call Bruce Campbell and tell him why SKTO is one of the "winners."
Bruce Campbell , a fund manager with StoneCastle Investment Management Inc., said investors should buy a basket of marijuana companies instead of trying to pick a winner out of a group of small, thinly-traded stocks. “You want to do it with a basket, knowing a couple of them will blow up and do really well, with the rest somewhere in the middle,” Campbell said on the phone from Kelowna, British Columbia. He helps manage about C$100 million ($92.4 million) with the firm. “Your basket will probably give you some good returns over the next five to 10 years.”
Pot Shares Rally 21% to 1,700% as Speculators See Green
By Nick Taborek, Callie Bost and Nikolaj Gammeltoft 2014-01-09
Marijuana buds.
They’ve got high hopes.
Bruce Perlowin, the chief executive officer of Hemp Inc. (HEMP) who has seen his stock soar 205 percent to 8 cents in the last three days, says investors are suddenly bidding up marijuana companies because they want to find “the next Microsoft.” Robert Frichtel, his Advanced Cannabis Solutions Inc. up 144 percent after posting $455 in sales last quarter, said “euphoria” is driving gains that in some cases top 1,700 percent.
“The demand for marijuana is insatiable,” said Perlowin, a once-jailed smuggler who filed last month to sell 12 million shares of the Las Vegas-based company even as its market value holds at 99.97 percent below the world’s biggest software maker. “You have a feeding frenzy for the birth of a new industry.”
While regulators warn of scams, some of the biggest percentage gains in the stock market this year are being enjoyed by investors speculating on marijuana penny stocks. GreenGro Technologies Inc. (GRNH), which provides management services for medical dispensaries, has soared 1,714 percent to 80 cents. Tranzbyte Corp. (ERBB), which sells pot in Colorado, has gained more than 310 percent in five trading sessions, crossing above a penny for the first time in 11 months.
Frenzy is afoot after Colorado became the first state to legalize sales to anyone 21 and older and New York considered reviving a law to allow some hospitals to use the drug for patients with cancer, glaucoma and other illnesses. Among 10 marijuana-related stocks that have rallied more than 20 percent this year, most are priced below $1 and trade over the counter.
‘Freaking Out’
“It’s people freaking out, thinking they found the next home run and doing no research,” Frank Ingarra, head trader at Greenwich, Connecticut-based NorthCoast Asset Management LLC, said by phone. “There might be one or two that survive, but having seen crazes like this, people have been burned by them a lot. The average investor should think twice.”
The Financial Industry Regulatory Authority issued an alert in August saying investors should beware of potentially fraudulent purveyors of stocks connected to pot and related services. Scammers may be promoting the shares, then selling them in what’s called a “pump-and-dump” scheme, the brokerage watchdog organization said in an e-mailed statement. It didn’t name any companies.
Finra Warning
Investors should be particularly wary of executives who have been incarcerated, according to Finra’s alert, which mentioned an unnamed CEO who spent nine years in prison for running one of the largest drug-smuggling operations in history. Perlowin of Hemp Inc. said in an August interview that he thought the group meant him and that it’s “absurd” to criticize him for his experience dealing marijuana.
Hemp Inc. focuses on industrial hemp used in clothing and camping gear, Perlowin noted.
“I don’t really know that there’s a lot of stock-market money to be made in this,” Brian Barish, president of Denver-based Cambiar Investors LLC, which manages $9 billion, said in a telephone interview. “I’ve definitely seem some interest and gotten a couple calls. Most of them have been with chuckles on the other end of the line.”
Eighteen states and Washington, D.C., allow the medical use of marijuana and 11 permit sales through dispensaries, according to the Denver-based National Conference of State Legislatures. National legalization has the potential to start a $35 billion to $45 billion a year industry, according to Bloomberg Industries.
Recreational Use
Pot for recreational use sells for an average of $400 an ounce, compared with $200 an ounce that Colorado retailers collect for medical marijuana, according to Aaron Smith, executive director of the National Cannabis Industry Association, a Washington-based trade group.
Medbox Inc. (MDBX), which has a market value of $626 million, climbed to a one-year high of $73.90 on Jan. 7. The West Hollywood, California-based company had about $260,000 in profit on sales of $2.1 million in the third quarter of 2013, according to a Nov. 19 statement. The shares slumped 19 percent to $43.25 today.
Advanced Cannabis, which leases space to producers and vendors, has climbed to $7.95 this year from $3.25. The Colorado Springs, Colorado-based company reported a $472,000 loss on $455 in sales in the quarter ending Sept. 30. The shares lost 7.6 percent to $7.35 today.
Building Momentum
“We kind of anticipated this happening with the euphoria that happens around the cannabis space with any significant news,” Frichtel, president and chief executive officer of Advanced Cannabis, said in a telephone interview. “Momentum is just starting to build behind the industry and I assure we’ll do everything right to continue to promote shareholder value.”
GreenGro Technologies has climbed to 80 cents a share from 4 cents at the end of last year. The Anaheim, California-based company reported a net loss of $221,644 during the third quarter. Growlife Inc. (PHOT), which makes indoor growing equipment, has climbed to 35 cents a share from 15 cents in 2013. Tranzbyte, which has a market value of $29 million, has risen to 1 cent from 0.29 cent.
“We appreciate the confidence of investors,” Marco Hegyi, president of Woodland Hills, California-based Growlife, said in an e-mail to Bloomberg News. “We are essential to the expansion of the legal cannabis market.”
Past Frenzies
U.S. investors poured money into Chinese stocks in 2009 that went public via reverse mergers amid optimism about the world’s second-biggest economy. The gains were erased over the following two years as the global financial crisis unfolded and some of the stocks were targeted by short sellers.
Zoom Technologies Inc. (ZOOM), a Chinese maker of phone equipment, jumped to $126.27 in 2009 from about $4 in about six months in 2009. The stock has since lost all of those gains. Universal Travel Group. reached $16.83 in 2009 from about $1.50 the previous year. The Chinese travel service traded at 16 cents in 2013 before it was delisted.
“It’s very easy to see why day traders love a penny name,” said Yousef Abbasi, market strategist at JonesTrading Institutional Services LLC, a Westlake, California-based broker, referring to the ticker symbol for Medical Marijuana. “They love the hype surrounding these names and there is constant news flow.”
Cannabis Science
Medical Marijuana Inc. (MJNA) shares trade at 19 cents, up 21 percent since Dec. 31. AVT Inc. (AVTC), which makes vending machine technology, is up almost 300 percent this year. Cannabis Science Inc. (CBIS) has more than doubled to 12 cents. mCig Inc. (MCIG), an electronic-cigarette producer, has risen 54 percent to 14 cents a share.
A phone call to Medical Marijuana was not immediately returned. Shannon Illingworth, founder of AVT in Corona, California, wasn’t available for comment. Messages left with investor relations at mCig, GreenGro Technologies, Tranzbyte and Medbox weren’t returned.
Bruce Campbell, a fund manager with StoneCastle Investment Management Inc., said investors should buy a basket of marijuana companies instead of trying to pick a winner out of a group of small, thinly-traded stocks.
“You want to do it with a basket, knowing a couple of them will blow up and do really well, with the rest somewhere in the middle,” Campbell said on the phone from Kelowna, British Columbia. He helps manage about C$100 million ($92.4 million) with the firm. “Your basket will probably give you some good returns over the next five to 10 years.”
To contact the reporters on this story: Nick Taborek in New York at ntaborek@bloomberg.net; Callie Bost in New York at cbost2@bloomberg.net; Nikolaj Gammeltoft in New York at ngammeltoft@bloomberg.net
To contact the editor responsible for this story: Lynn Thomasson at lthomasson@bloomberg.net
http://www.bloomberg.com/news/2014-01-09/pot-...green.html